Galectin Therapeutics Inc. (NASDAQ:GALT) will present at the Jefferies 2014 Global Healthcare Conference in New York City. Galectin Therapeutics Inc. (NASDAQ:GALT) stock performance was 3.20% in last session and finished the day at $13.22. Traded volume was 165.10K shares in the last session and the average volume of the stock remained 417.97K shares. The beta of the stock remained 1.62. Galectin Therapeutics Inc. (NASDAQ:GALT) insider … Continue reading Market Movers: Galectin Therapeutics Inc. (NASDAQ:GALT), Sagent Pharmaceuticals Inc (NASDAQ:SGNT), Weibo Corp (ADR) (NASDAQ:WB), Qihoo 360 Technology Co Ltd (NYSE:QIHU)